93 related articles for article (PubMed ID: 11387323)
1. Expression of serotonin receptors in bone.
Westbroek I; van der Plas A; de Rooij KE; Klein-Nulend J; Nijweide PJ
J Biol Chem; 2001 Aug; 276(31):28961-8. PubMed ID: 11387323
[TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.
Bliziotes MM; Eshleman AJ; Zhang XW; Wiren KM
Bone; 2001 Nov; 29(5):477-86. PubMed ID: 11704501
[TBL] [Abstract][Full Text] [Related]
3. The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.
Collet C; Schiltz C; Geoffroy V; Maroteaux L; Launay JM; de Vernejoul MC
FASEB J; 2008 Feb; 22(2):418-27. PubMed ID: 17846081
[TBL] [Abstract][Full Text] [Related]
4. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.
Bliziotes M; Eshleman A; Burt-Pichat B; Zhang XW; Hashimoto J; Wiren K; Chenu C
Bone; 2006 Dec; 39(6):1313-21. PubMed ID: 16884969
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of 5-hydroxytryptophan aggravated periodontitis-induced alveolar bone loss in rats.
Li X; Wu X; Ma Y; Hao Z; Chen S; Fu T; Chen H; Wang H
Arch Oral Biol; 2015 May; 60(5):789-98. PubMed ID: 25766472
[TBL] [Abstract][Full Text] [Related]
6. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.
Lee GS; Simpson C; Sun BH; Yao C; Foer D; Sullivan B; Matthes S; Alenina N; Belsky J; Bader M; Insogna KL
J Bone Miner Res; 2014 Apr; 29(4):976-81. PubMed ID: 24038240
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function.
Hodge JM; Wang Y; Berk M; Collier FM; Fernandes TJ; Constable MJ; Pasco JA; Dodd S; Nicholson GC; Kennedy RL; Williams LJ
Biol Psychiatry; 2013 Jul; 74(1):32-9. PubMed ID: 23260229
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and fluoxetine modulate bone cell function in vitro.
Gustafsson BI; Thommesen L; Stunes AK; Tommeras K; Westbroek I; Waldum HL; Slørdahl K; Tamburstuen MV; Reseland JE; Syversen U
J Cell Biochem; 2006 May; 98(1):139-51. PubMed ID: 16408289
[TBL] [Abstract][Full Text] [Related]
9. Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats.
Gustafsson BI; Westbroek I; Waarsing JH; Waldum H; Solligård E; Brunsvik A; Dimmen S; van Leeuwen JP; Weinans H; Syversen U
J Cell Biochem; 2006 Apr; 97(6):1283-91. PubMed ID: 16329113
[TBL] [Abstract][Full Text] [Related]
10. Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and phospholipase A2 activation.
Locker M; Bitard J; Collet C; Poliard A; Mutel V; Launay JM; Kellermann O
Cell Signal; 2006 May; 18(5):628-39. PubMed ID: 16014328
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.
Warden SJ; Robling AG; Sanders MS; Bliziotes MM; Turner CH
Endocrinology; 2005 Feb; 146(2):685-93. PubMed ID: 15539550
[TBL] [Abstract][Full Text] [Related]
12. Serotonin regulates osteoclast differentiation through its transporter.
Battaglino R; Fu J; Späte U; Ersoy U; Joe M; Sedaghat L; Stashenko P
J Bone Miner Res; 2004 Sep; 19(9):1420-31. PubMed ID: 15312242
[TBL] [Abstract][Full Text] [Related]
13. Skeletal effects following developmental flame-retardant exposure are specific to sex and chemical class in the adult Wistar rat.
Schkoda S; Horman B; Witchey SK; Jansson A; Macari S; Patisaul HB
Front Toxicol; 2023; 5():1216388. PubMed ID: 37577032
[No Abstract] [Full Text] [Related]
14. Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling.
Weerasinghe DK; Hodge JM; Pasco JA; Samarasinghe RM; Azimi Manavi B; Williams LJ
Front Cell Dev Biol; 2023; 11():1184550. PubMed ID: 37305679
[TBL] [Abstract][Full Text] [Related]
15. The Serotonergic System and Bone Metabolism During Pregnancy and Lactation and the Implications of SSRI Use on the Maternal-Offspring Dyad.
Fricke HP; Hernandez LL
J Mammary Gland Biol Neoplasia; 2023 Apr; 28(1):7. PubMed ID: 37086330
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density response to antiosteoporotic drugs in older depressed adults.
Efendioglu EM; Cigiloglu A; Ozturk E; Ozturk ZA
Arch Osteoporos; 2023 Feb; 18(1):31. PubMed ID: 36781548
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis.
Klavdianou K; Kanellou A; Daoussis D
Mediterr J Rheumatol; 2022 Mar; 33(Suppl 1):115-125. PubMed ID: 36127924
[TBL] [Abstract][Full Text] [Related]
18. The relationship between osteoporosis and depression.
Kashfi SS; Abdollahi G; Hassanzadeh J; Mokarami H; Khani Jeihooni A
Sci Rep; 2022 Jul; 12(1):11177. PubMed ID: 35778459
[TBL] [Abstract][Full Text] [Related]
19. Uncovering Hidden Mechanisms of Different Prescriptions Treatment for Osteoporosis
Liu Y; Liu Q; Yin C; Li Y; Wu J; Chen Q; Yu H; Lu A; Guan D
Front Cell Dev Biol; 2022; 10():831894. PubMed ID: 35211473
[TBL] [Abstract][Full Text] [Related]
20. Housing Temperature Influences Atypical Antipsychotic Drug-Induced Bone Loss in Female C57BL/6J Mice.
Kunst RF; Langlais AL; Barlow D; Houseknecht KL; Motyl KJ
JBMR Plus; 2021 Oct; 5(10):e10541. PubMed ID: 34693191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
